Delcath Systems, Inc. DCTH
15.60
(0.48)
(2.99%)
as of 25 Sep
- Market cap
- $558.0M
- P/E
- 1,560×
Follow DCTH
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
537.50 | 126.25 | 464.00 | 1,259.00 |
P/S ratio |
4.91 | 4.24 | 3.70 | 4.74 | |
P/FCF ratio |
32.50 | 17.25 | 17.42 | 25.81 | |
P/Operating CF |
81.96 | 43.86 | 390.05 | 79.11 | |
P/B ratio |
3.41 | 3.25 | 2.97 | 3.73 | |
Price to Tangible BV |
3.41 | 3.25 | 2.97 | 3.73 | |
EV/Sales |
3.82 | 3.20 | 2.73 | 3.75 | |
EV/EBITDA |
63.15 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
22.94 | 12.11 | 11.67 | 18.27 | |
EV/FCF |
25.27 | 13.01 | 12.87 | 20.45 | |
Quick Ratio |
12.82 | 9.39 | 9.67 | 8.42 | |
Current Ratio |
15.06 | 10.92 | 11.24 | 9.83 | |
Net Debt/EBITDA |
115.62 | 35.94 | 45.89 | (45.07) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.02 | 0.85 | 0.85 | 0.75 | |
Operating CF/Net income |
5.75 | (4.35) | (0.80) | 2.14 | |
Capex/Depreciation |
1.20 | 1.58 | 1.84 | 1.88 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
38.84% | 45.21% | 39.31% | 35.63% | |
Selling, General and Administrative Expense of Revenue |
50.29% | 50.81% | 52.30% | 45.90% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
27.47% | 21.77% | 19.79% | 17.57% | |
Graham Net Nets |
0.28 | 0.30 | 0.32 | 0.25 | |
Graham Number |
1.19 | 2.36 | 1.19 | 0.87 | |
Earnings Yield |
0.19% | 0.79% | 0.22% | 0.08% | |
Free Cash Flow Yield |
3.08% | 5.80% | 5.74% | 3.87% | |
Revenue per Share |
0.57 | 0.58 | 0.69 | 0.81 | |
Operating CF per Share |
0.13 | 0.23 | 0.02 | 0.16 | |
Capex per Share |
(0.01) | (0.02) | (0.02) | (0.01) | |
Free Cash Flow per Share |
0.12 | 0.21 | 0.01 | 0.15 | |
Cash per Share |
2.44 | 2.54 | 2.48 | 2.67 | |
Shareholders Equity per Share |
3.16 | 3.10 | 3.13 | 3.38 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.16 | 3.10 | 3.13 | 3.38 | |
Free Cash Flow |
4.31 | 7.70 | 0.29 | 5.21 | |
Working Capital |
112.60 | 108.58 | 109.57 | 117.26 | |
Capital Expenditures |
(0.46) | (0.55) | (0.57) | (0.50) | |
Net Current Asset Value |
111.17 | 107.12 | 108.14 | 114.66 | |
EV/EBIT |
51.71 | 413.27 | 0.00 | 0.00 | |
Capex to Sales |
0.02 | 0.03 | 0.02 | 0.02 | |
Net Profit Margin |
4.04% | (9.15%) | (4.28%) | 9.16% | |
Price to Operating Income |
66.48 | 548.17 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
10.34 | 11.32 | 14.05 | 15.89 | |
Average Payables |
1.54 | 1.81 | 2.54 | 4.36 | |
Average Inventory |
8.69 | 8.59 | 8.47 | 11.12 | |
Average Assets |
77.99 | 100.11 | 106.08 | 126.95 | |
Average Common Equity |
61.71 | 89.98 | 96.47 | 113.07 |
Columns are period end dates